Sodium Channel Blocker Cuts Post-Surgery Pain

(MedPage Today) -- The sodium channel blocker LTG-001, an investigational selective Nav1.8 inhibitor, reduced pain scores more than placebo for 2 days after abdominoplasty, a phase IIb trial showed.
The primary endpoint was the time-weighted sum...